Cargando…
Immune regulators in transfer factor : [proceedings] /
Immune Regulators In Transfer Factor.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , , |
| Formato: | Electrónico Congresos, conferencias eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Academic Press,
1979.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn607911274 | ||
| 003 | OCoLC | ||
| 005 | 20231117033047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 100418s1979 nyua ob 101 0 eng d | ||
| 010 | |z 79001464 | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d OCLCQ |d OPELS |d OCLCO |d N$T |d IDEBK |d E7B |d OCLCQ |d OCLCF |d OCLCQ |d OCLCA |d YDXCP |d EBLCP |d UKDOC |d DEBSZ |d OCLCO |d OCLCQ |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCL |d OCLCO |d OCLCQ |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d OCLCQ |d OCLCA |d OCLCQ |d LEAUB |d VLY |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCQ | ||
| 019 | |a 643621935 |a 836401360 |a 1086507333 |a 1162145173 | ||
| 020 | |a 9780323142540 |q (electronic bk.) | ||
| 020 | |a 0323142540 |q (electronic bk.) | ||
| 020 | |z 9780124060609 | ||
| 020 | |z 0124060609 | ||
| 020 | |a 1299398804 | ||
| 020 | |a 9781299398801 | ||
| 035 | |a (OCoLC)607911274 |z (OCoLC)643621935 |z (OCoLC)836401360 |z (OCoLC)1086507333 |z (OCoLC)1162145173 | ||
| 042 | |a dlr | ||
| 050 | 4 | |a QR185.8.T67 |b I57 1978 | |
| 060 | 4 | |a W3 |b IN924RI 3d 1978i | |
| 060 | 4 | |a QW 568 |b I615 1978i | |
| 072 | 7 | |a MED |x 044000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.07/9 |2 22 |
| 111 | 2 | |a International Symposium on Transfer Factor |n (3rd : |d 1978 : |c Wadley Institutes of Molecular Medicine) | |
| 245 | 1 | 0 | |a Immune regulators in transfer factor : |b [proceedings] / |c edited by Amanullah Khan, Charles H. Kirkpatrick, N.O. Hill. |
| 260 | |a New York : |b Academic Press, |c 1979. | ||
| 300 | |a 1 online resource (xxiii, 760 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and indexes. | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Immune Regulators in Transfer Factor; Copyright Page; Table of Contents; LIST OF PARTICIPANTS; PREFACE; ACKNOWLEDGMENTS; SECTION I: ANIMAL MODELS; CHAPTER 1. INTRODUCTORY REMARKS; CHAPTER 2. MODULATION OF SUPPRESSOR ACTIVITY BY TREATMENT WITH DIALYZABLE LEUCOCYTE EXTRACT; INTRODUCTION; MATERIALS AND METHODS; RESULTS AND DISCUSSION; REFERENCES; DISCUSSION; CHAPTER 3. EVIDENCE FOR SPECIFIC AND NONSPECIFIC EFFECTS OF DIALYZABLE LEUKOCYTE EXTRACTS(CONTAINING TRANSFER FACTOR ACTIVITY) IN MICE; Results; Discussion; Acknowledgment; References; DISCUSSION. | |
| 505 | 8 | |a Chapter 4. a murine model for studying the transfer of dth with dialysable human transfer factor1i. introduction; ii. materials and methods; iii. results; iv. discussion; references; discussion; chapter 5. bovine dialyzable transfer factor: stimulation of antigen-specific leukocyte reactivity in c57bl/6 mice; introduction; materials and methods; results; discussion; disclaimer statement; references; discussion; chapter 6. guinea-pig as an experimental model for testing activity and specificityof human and bovine transfer factor1; i. introduction; ii. human dle activity in guinea pigs. | |
| 505 | 8 | |a III. BOVINE DLE ACTIVITYIV. DISCUSSION; REFERENCES; DISCUSSION; CHAPTER 7. SPECIFICITY DETERMINANTS OF DIALYSABLE TRANSFER FACTOR (DTF)IN THE RHESUS MONKEY MODEL; I INTRODUCTION AND SUMMARY; II METHODS AND DESIGN; Ill RESULTS; IV DISCUSSION AND CONCLUSIONS; ACKNOWLEDGMENTS; REFERENCES; DISCUSSION; CHAPTER 8. NONSPECIFICITY OF THE TRANSFER OF KLH HYPERSENSITIVITYTO MARMOSET MONKEYS WITH TFd PREPARED FROM THELEUCOCYTES OF KLH-SENSITIVE RHESUS MONKEYS; REFERENCES; DISCUSSION. | |
| 505 | 8 | |a Chapter 9.the in vitro augmentation of antigen-induced proliferation of spleen cells obtainedfrom human dialyzable leukocyte lysate(hdll)-recipient mice sensitized to klhreferences; discussion; chapter 10.detection of a new protein component in canine plasma after transfer factor administration: correlation with delayed-type skin reactivity; i. introduction; ii. materials and methods; iii. results; iv. discussion; acknowledgments; references; discussion; chapter 11.summation and general discussion; section ii: in vitro testing; chapter 12.introductory remarks. | |
| 505 | 8 | |a CHAPTER 13. INDUCTION OF CORTISONE RESISTANCE AND INCREASED MITOGEN RESPONSIVENESS IN THYMOCYTES BY TRANSFER FACTORMATERIALS AND METHODS; RESULTS; REFERENCES; DISCUSSION; CHAPTER 14. EFFECTS OF TRANSFER FACTOR (TF) AND THYMOSIN ON THERECOVERY OF E-ROSETTING CAPACITY IN TRYPSINISED LYMPHOCYTES; MATERIALS AND METHODS; RESULTS; DISCUSSION; REFERENCES; DISCUSSION; CHAPTER 15. CONTRIBUTION OF PROSTAGLANDINS TO THE BIOLOGICAL ACTIVITYOF DIALYZABLE LEUKOCYTE EXTRACTS CONTAINING TRANSFER FACTOR ACTIVITY; Acknowledgment; References; DISCUSSION. | |
| 520 | |a Immune Regulators In Transfer Factor. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Transfer factor (Immunology) |v Congresses. | |
| 650 | 0 | |a Immune response |x Regulation |v Congresses. | |
| 650 | 0 | |a Transfer factor (Immunology) |x Therapeutic use |v Congresses. | |
| 650 | 0 | |a Transfer factor (Immunology) | |
| 650 | 0 | |a Immunology |v Congresses. | |
| 650 | 0 | |a Immunotherapy |x Congresses. | |
| 650 | 2 | |a Transfer Factor |0 (DNLM)D014165 | |
| 650 | 6 | |a Immunologie |0 (CaQQLa)201-0066630 |v Congr�es. |0 (CaQQLa)201-0378219 | |
| 650 | 6 | |a R�eaction immunitaire |0 (CaQQLa)201-0018274 |x R�egulation |0 (CaQQLa)201-0018274 |v Congr�es. |0 (CaQQLa)201-0378219 | |
| 650 | 6 | |a Immunoth�erapie |0 (CaQQLa)201-0067406 |x Congr�es. |0 (CaQQLa)201-0378208 | |
| 650 | 6 | |a Facteur de transfert (Immunologie) |0 (CaQQLa)201-0127537 |v Congr�es. |0 (CaQQLa)201-0378219 | |
| 650 | 6 | |a Facteur de transfert (Immunologie) |0 (CaQQLa)201-0127537 |x Emploi en th�erapeutique |0 (CaQQLa)201-0373975 |v Congr�es. |0 (CaQQLa)201-0378219 | |
| 650 | 6 | |a Facteur de transfert (Immunologie) |0 (CaQQLa)201-0127537 | |
| 650 | 7 | |a MEDICAL |x Immunology. |2 bisacsh | |
| 650 | 7 | |a Immunotherapy |2 fast |0 (OCoLC)fst00968044 | |
| 650 | 7 | |a Immunology |2 fast |0 (OCoLC)fst00968006 | |
| 650 | 7 | |a Immune response |x Regulation |2 fast |0 (OCoLC)fst00967872 | |
| 650 | 7 | |a Transfer factor (Immunology) |2 fast |0 (OCoLC)fst01154601 | |
| 650 | 7 | |a Transfer factor (Immunology) |x Therapeutic use |2 fast |0 (OCoLC)fst01154603 | |
| 655 | 2 | |a Congress |0 (DNLM)D016423 | |
| 655 | 7 | |a proceedings (reports) |2 aat |0 (CStmoGRI)aatgf300027316 | |
| 655 | 7 | |a Conference papers and proceedings |2 fast |0 (OCoLC)fst01423772 | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congr�es. |2 rvmgf |0 (CaQQLa)RVMGF-000001049 | |
| 700 | 1 | |a Khan, Amanullah, |d 1940- | |
| 700 | 1 | |a Kirkpatrick, Charles H. | |
| 700 | 1 | |a Hill, N. O. |q (Norwood Oakley), |d 1936- | |
| 776 | 0 | 8 | |i Print version: |a International Symposium on Transfer Factor (3rd : 1978 : Wadley Institutes of Molecular Medicine). |t Immune regulators in transfer factor. |d New York : Academic Press, 1979 |z 9780124060609 |w (DLC) 79001464 |w (OCoLC)4665030 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780124060609 |z Texto completo |